Specific Biomarkers of Liver Fibrosis Suboptimal in HIV/HCV Coinfection
APRI and FIB-4 biomarkers may be unsatisfactory for the detection of significant fibrosis and cirrhosis in people with HIV and HCV.
Hepatitis
Universal Prenatal Hepatitis C Virus Screening Improves Health Outcomes
Universal prenatal HCV screening was found to be cost-effective and improved health outcomes in women diagnosed with HCV infection and identification of HCV exposure in neonates.
HBV, HCV, and HIV Screening Results of Deceased Solid Organ Donors
Increased risk donors may be significantly more likely to be HCV- and HBV-positive compared with standard risk donors.
Clinical Features and Determinants of Chronic Hepatitis E Infection
The Journal of Viral Hepatitis has published a review of the clinical manifestations of chronic hepatitis E virus.
Noninvasive Biomarker of Variceal Bleeding in HCV Cirrhosis
Although hepatic vein pressure gradient measurement is an accurate method for evaluation of portal HTN, this technique is invasive and not widely available.
Many Patients Are Unwilling to Accept Transplantation of an HCV-Positive Organ
The availability of organs that are positive for HCV can potentially decrease the length of time on organ transplantation waitlists.
Sofosbuvir-Velpatasvir Safe and Effective for Some Patients With Chronic HCV
Sofosbuvir-velpatasvir administered for 12 weeks is efficacious and safe for Asian patients with chronic HCV.
Alkaline Phosphatase Threshold Marks Significant Fibrosis in Hepatitis B
Levels of serum alkaline phosphatase above 69.5 IU/L can distinguish significant fibrosis in individuals with chronic HBV who are e-antigen-negative.
Hepatitis A Vaccine Safe in Childhood-Onset SLE
Inactivated hepatitis A vaccine may be safe and well tolerated in childhood-onset systemic lupus erythematosus.
High Hepatitis C Prevalence in Western and Appalachian US States
In the US, the prevalence of HCV is comparatively higher in the western and Appalachian states.
Next post in Hepatitis
